From cytogenetics to cytogenomics of adipose tissue tumors 2. Malignant adipose tissue tumors;De la cytogénétique à la cytogénomique des tumeurs adipocytaires 2. Tumeurs adipocytaires malignes

Bulletin du Cancer

Volumn 91, Issue 4, 2004, Pages 317-323

  Pedeutour, Florence ^a   Maire, Georges ^a   Sirvent, Nicolas ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

Adipose tissue tumor; Chromosome; Cytogenetic; Liposarcoma; Molecular genetics

Indexed keywords

ADIPOSE TISSUE; CELL DIFFERENTIATION; CENTROMERE; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CYTOGENETICS; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; GENE TRANSLOCATION; GENETIC ANALYSIS; HUMAN; LIPOSARCOMA; MOLECULAR GENETICS; MYXOSARCOMA; REVIEW;

CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 16; CYTOGENETICS; FLOW CYTOMETRY; GENE AMPLIFICATION; HUMANS; LIPOSARCOMA; LIPOSARCOMA, MYXOID; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TRANSLOCATION, GENETIC; ZINC FINGERS;

EID: 2442692650     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Weiss SW. Enzinger and Weiss's soft tissue tumors. In: Weiss SW, Goldblum JR, eds, edition. St-Louis : Mosby Inc, 2001.
2. Fletcher CDM, Unni KK, Mertens F. World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bones. First ed. Lyon : IARC press, 2002.
3. Mitelman F, Johansson B, Mertens F. Mitelman database of chromosome aberrations in cancer, 2003. http ://cgap.nci.nih.gov/Chromosomes/Mitelman.
4. Mandahl N. Liposarcoma/malignant lipomatous tumors. Atlas Genet Cytogenet Oncol Haematol 2000. http ://www.infobiogen.fr/services/chromcancer/tumors/ liposarc5029.html.
5. Mandahl N, Mertens F, Willén H, Rydholm A, Kreicbergs A, Mitelman F. Nonrandom pattern of telomeric associations in atypical lipomatous tumors with rings and giant marker chromosomes. Cancer Genet Cytogenet 1998 ; 103 : 25-34.
6. Pedeutour F, Suijkerbuijk RF, Forus A, Van Gaal J, Van de Klundert W, Coindre JM et al. Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma. Genes Chromosomes Cancer 1994 ; 10 : 85-94.
7. Soussi T. Gène : hdm2 (mdm2 chez la souris) human double minute 2. Bull Cancer 2000 ; 87 : 619-20.
8. Pedeutour F, Forus A, Coindre JM, Berner JM, Nicolo G, Michiels JF et al. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 1999 ; 24 : 30-41.
9. Hainaut P. p53 (TP53) Le gène suppresseur de tumeurs TP53 : vingt ans (et dix mille mutations) après. Bull Cancer 2000 ; 87 : 11-8.
10. Pilotti S, Della Torre G, Lavarino C, Di Palma S, Sozzi G, Minoletti F et al. Distinct mdm2/p53 expression patterns in liposarcoma subgroups : implications for different pathogenetic mechanisms. J Pathol 1997 ; 181 : 14-24.
11. Schneider-Stock R, Walter H, Radig K, Rys J, Bosse A, Khunen C et al. MDM2 amplification and loss of heterozygosity at Rb and p53 genes : no simultaneous alterations in the oncogenesis of liposarcomas. J Cancer Res Clin Oncol 1998 ; 124 : 532-40.
12. Sirvent N, Forus A, Lescaut W, Burel F, Benzaken S, Chazal M, et al. Characterization of centromere alterations in liposarcomas. Genes Chromosomes Cancer 2000 ; 29 : 117-29.
13. Amor DJ, Choo KH. Neocentromeres : role in human disease, evolution, and centromere study. Am J Hum Genet 2002 ; 71 : 695-714.
14. Coindre JM, de Loynes B, Bui NB, Stockle E, de Mascarel I, Trojani M. Liposarcome dédifférencié. Étude anatomoclinique de 6 cas. Ann Pathol 1992 ; 12 : 20-8.
15. Coindre JM, Mariani O, Chibon F, Mairal A, De Saint-Aubain Somerhausen N, Favre-Guillevin E, et al. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas : a review of 25 cases initially diagnosed as malignant fibrous histiocytoma. Mod Pathol 2003 ; 16 : 256-62.
16. Mertens F, Fletcher CD, Dal Cin P, de Wever I, Mandahl N, Mirelman F, et al. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features : a report of the CHAMP study group. Genes Chromosomes Cancer 1998 ; 22 : 16-25.
17. Meis-Kindblom JM, Sjögren H, Kindblom LG, Peydro-Mellquist A, Roijer E, Aman P, et al. Cytogenetic and molecular genetic analyses of liposarcoma and its soft tissue simulators : recognition of new variants and differential diagnosis. Virchows Arch 2001 ; 439 : 141-51.
18. Fritz B, Schubert F, Wrobel G, Schwaenen C, Wessendorf S, Nessling M et al. Microarray-based copy number and expression profiling in dedifferentiated pleiomorphic liposarcoma. Cancer Res 2002 ; 62 : 2993-8.
19. Chibon F, Mariani O, Derré J, Malinge S, Coindre JM, Guillou L et al. A subgroup of malignant fibrous histiocytomas is associated with genetic changes similar to those of well-differentiated liposarcomas. Cancer Genet Cytogenet 2002 ; 139 : 24-9.
20. Tutc-Carel C, Limon J, Dal Cin P, Rao U, Karakousis C, Sandberg AA. Cytogenetic studies of adipose tissue tumors. II. Recurrent reciprocal translocation t(12;16)(q13;p11) in myxoid liposarcomas. Cancer Genet Cytogenet 1986 ; 23 : 291-9.
21. Altungoz O, Meloni AM, Peier A, Zalupski M, Spanier S, Brooks JSJ et al. Deletion 6q in three cases of mixed-type liposarcoma in addition to t(12;16)(q13;p11). Cancer Genet Cytogenet 1995 ; 79 : 104-10.
22. Rabbitts TH, Forster A, Larson R, Nathan P. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nature Genet 1993 ; 4 : 175-80.
23. Ashar HR, Schoenberg Fejzo M, Tkachenko A, Zhou X, Fletcher JA, Weremowicz S et al. Disruption of the architectural factor HMGI-C : DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 1995 ; 82 : 57-65.
24. Panagopoulos I, Mandahl N, Ron D, Höglund M, Nilbert M, Mertens F et al. Characterization of the CHOP breakpoints and fusion transcripts in myxoid liposarcomas with the 12;16 translocation. Cancer Res 1994 ; 54 : 6500-3.
25. Kanoe H, Nakayama T, Hosaka T, Murakami H, Yamamoto H, Nakashima Y et al. Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of translin and topoisomerase in the process of translocation. Oncogene 1999 ; 18 : 721-9.
26. Panagopoulos I, Höglund M, Mertens F, Mandahl N, Mitelman F, Aman P. Fusion of the EWS and CHOP genes in myxoid liposarcoma. Oncogene 1996 ; 12 : 489-94.
27. Ichikawa H, Shimizu K, Hayashi Y, Ohki M. An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. Cancer Res 1994 ; 54 : 2865-8.
28. Sreekantaiah C, Karakousis CP, Leong SP, Sandberg AA. Cytogenetic findings in liposarcomas correlate with histopathologic subtypes. Cancer 1992 ; 69 : 2484-95.
29. Nilbert M, Rydholm A, Willèn H, Mitelman F, Mandahl N. MDM2 gene amplification correlates with ring chromosomes in soft tissue tumors. Genes Chromosomes Cancer 1994 ; 9 : 261-5.
30. Szymanska J, Tarkkanen M, Wiklund T, Virolainen M, Blomqvist C, Asko-Selijavaara S et al. Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridisation. Genes Chromosomes Cancer 1996 ; 15 : 89-94.
31. Scolozzi P, Lombardi T, Maire G, Pedeutour F, Richter M. Infiltrating intramuscular lipoma of the temporal muscle. A case report with molecular Cytogenetic analysis. Oral Oncol 2003 ; 39 : 316-22.
32. Hostein I, Pelmus M, Aurias A, Pedeutour F, Mathoulin-Pélissier S, Coindre JM. Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin-embedded material : a potential tool for the diagnosis of atypical lipomatous tumors/well-differentiated liposarcomas. J Pathol 2004 ; 202 : 95-102.
33. Bertucci F, Loriod B, Tagett R, Granjeaud S, Birnbaum D, Nguyen C et al. Puces à ADN : technologie et applications. Bull Cancer 2001 ; 288 : 243-52.
34. Pedeutour F, Foa C et le groupe français de cytogéné tique oncologique. De la cytogénétique à la cytogénomique des tumeurs adipocytaires. 1. Tumeurs adipocytaires bénignes. Bull Cancer 2002 ; 89 : 689-95.